Phase
Condition
Organ Transplant
Heart Valve Disease
Treatment
tricuspid valve replacement
Clinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with primary tricuspid valve disease and/or tricuspid bioprosthetic failurescheduled for tricuspid valve intervention.
Intraoperative findings suggested for tricuspid valve replacement rather thanrepair.
Exclusion
Exclusion Criteria:
Pregnancy
Confirmed active drug addiction
Progressive HIV-infection
HIV-infected patients with CD4-cells count less than 250
Patients with secondary tricuspid valve pathology (left-sided valve disease)
LV Ejection fraction less than 40%
Study Design
Study Description
Connect with a study center
Department of Cardiac Surgery
Chelyabinsk,
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.